Table of Content



Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Study design
1.1.2. Indication
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1: Understanding the market dynamics
1.9.2. Objective 2: Understanding the market estimates and forecasts
1.9.3. Objective 3: Understanding the attributes such as strategy framework, competitor categorization
1.9.4. Objective 4: Understanding the key product and application scopes to conclude on the market size
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. North America & Europe Preclinical Medical Device Testing Services Market Variables, Trends & Scope
3.1. Market Lineage outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.1.1. Complexity in Product design
3.3.1.2. Intensifying Competition
3.3.1.3. Increase in number of small medical device lacking in-house testing capabilities
3.3.1.4. Strict Approval Norms
3.3.2. Market Restraint Analysis
3.3.2.1. Legal and Regulatory Issues
3.3.2.2. Delays in contractual obligation
3.3.3. Industry Challenges
3.4. North America & Europe Preclinical Medical Device Testing Services: Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier Power
3.4.1.2. Buyer Power
3.4.1.3. Substitution Threat
3.4.1.4. Threat from new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.5. COVID-19 pandemic impact on clinical trial activity
Chapter 4. North America & Europe Preclinical Medical Device Testing Services: Segment Analysis, By services, 2016 - 2028 (USD Million)
4.1. Segment Dashboard
4.2. Study Design Market Share Analysis, 2020&2028
4.3. Global North America & Europe Preclinical Medical Device Testing Services, By services, 2016 to 2028
4.4. Market Size & Forecasts and Trend Analyses, 2016 to 2028for the following
4.4.1. Biocompatibility Test
4.4.2. Chemistry Test
4.4.3. Microbiology Test & Sterility
4.4.3.1. Bioburden Determination
4.4.3.2. Pyrogen & Endotoxin Testing
4.4.3.3. Sterility Test and Validation
4.4.3.4. Antimicrobial activity testing
4.4.4.4. Others
4.4.4. Package Validation
Chapter 5. North America & Europe Preclinical Medical Device Testing Services: Regional Market Analysis, by region, 2016 - 2028 (USD Million)
5.1. Regional Market Dashboard
5.2. Regional Market Share Analysis, 2020&2028
5.3. Market Size, & Forecasts, and Trend Analysis, 2016 to 2028:
5.4. North America
5.4.1. Market estimates and forecast, by country, 2016 - 2028 (USD Million)
5.4.2. Market estimates and forecast, by services, 2016 - 2028 (USD Million)
5.4.3. Market estimates and forecast, by test type, 2016 - 2028 (USD Million)
5.4.4. U.S.
5.4.4.1. Market estimates and forecast, by services, 2016 - 2028 (USD Million)
5.4.4.2. Market estimates and forecast, by test type, 2016 - 2028 (USD Million)
5.4.5. Canada
5.4.5.1. Market estimates and forecast, by services, 2016 - 2028 (USD Million)
5.4.5.2. Market estimates and forecast, by test type, 2016 - 2028 (USD Million)
5.5. Europe
5.5.1. Market estimates and forecast, by country, 2016 - 2028 (USD Million)
5.5.2. Market estimates and forecast, by services, 2016 - 2028 (USD Million)
5.5.3. Market estimates and forecast, by test type, 2016 - 2028 (USD Million)
5.5.4. Germany
5.5.4.1. Market estimates and forecast, by services, 2016 - 2028 (USD Million)
5.5.4.2. Market estimates and forecast, by test type, 2016 - 2028 (USD Million)
5.5.5. U.K.
5.5.5.1. Market estimates and forecast, by services, 2016 - 2028 (USD Million)
5.5.5.2. Market estimates and forecast, by test type, 2016 - 2028 (USD Million)
5.5.6. France
5.5.6.1. Market estimates and forecast, by services, 2016 - 2028 (USD Million)
5.5.6.2. Market estimates and forecast, by test type, 2016 - 2028 (USD Million)
5.5.7. Italy
5.5.7.1. Market estimates and forecast, by services, 2016 - 2028 (USD Million)
5.5.7.2. Market estimates and forecast, by test type, 2016 - 2028 (USD Million)
5.5.8. Spain
5.5.8.1. Market estimates and forecast, by services, 2016 - 2028 (USD Million)
5.5.8.2. Market estimates and forecast, by test type, 2016 - 2028 (USD Million)
5.5.9. Netherlands
5.5.9.1. Market estimates and forecast, by services, 2016 - 2028 (USD Million)
5.5.9.2. Market estimates and forecast, by test type, 2016 - 2028 (USD Million)
5.5.10. Belgium
5.5.10.1. Market estimates and forecast, by services, 2016 - 2028 (USD Million)
5.5.10.2. Market estimates and forecast, by test type, 2016 - 2028 (USD Million)
5.5.11. Switzerland
5.5.11.1. Market estimates and forecast, by services, 2016 - 2028 (USD Million)
5.5.11.2. Market estimates and forecast, by test type, 2016 - 2028 (USD Million)
5.5.12. Russia
5.5.12.1. Market estimates and forecast, by services, 2016 - 2028 (USD Million)
5.5.12.2. Market estimates and forecast, by test type, 2016 - 2028 (USD Million)
5.5.13. Sweden
5.5.13.1. Market estimates and forecast, by services, 2016 - 2028 (USD Million)
5.5.13.2. Market estimates and forecast, by test type, 2016 - 2028 (USD Million)
Chapter 6. North America & Europe Preclinical Medical Device Testing Services Market - Competitive Analysis
6.1. Key companies profiled
6.1.1. SGS SA
6.1.1.1. Company Overview
6.1.1.2. Financial Performance
6.1.1.3. Product Benchmarking
6.1.1.4. Strategic Initiatives
6.1.2. Toxikon Inc.
6.1.2.1. Company Overview
6.1.2.2. Financial Performance
6.1.2.3. Product Benchmarking
6.1.2.4. Strategic Initiatives
6.1.3. Eurofins Scientific
6.1.3.1. Company Overview
6.1.3.2. Financial Performance
6.1.3.3. Product Benchmarking
6.1.3.4. Strategic Initiatives
6.1.4. Pace Analytical Services, Inc.
6.1.4.1. Company Overview
6.1.4.2. Financial Performance
6.1.4.3. Product Benchmarking
6.1.4.4. Strategic Initiatives
6.1.5. WuXiAppTec, Inc.
6.1.5.1. Company Overview
6.1.5.2. Financial Performance
6.1.5.3. Product Benchmarking
6.1.5.4. Strategic Initiatives
6.1.6. North American Science Associates, Inc.
6.1.6.1. Company Overview
6.1.6.2. Financial Performance
6.1.6.3. Product Benchmarking
6.1.6.4. Strategic Initiatives
6.1.7. T?V S?D A.G.
6.1.7.1. Company Overview
6.1.7.2. Financial Performance
6.1.7.3. Product Benchmarking
6.1.7.4. Strategic Initiatives
6.1.8. American Preclinical Services
6.1.8.1. Company Overview
6.1.8.2. Financial Performance
6.1.8.3. Product Benchmarking
6.1.8.4. Strategic Initiatives
6.1.9. Sterigenics International LLC
6.1.9.1. Company Overview
6.1.9.2. Financial Performance
6.1.9.3. Product Benchmarking
6.1.9.4. Strategic Initiatives
6.1.10. Charles River Laboratories International, Inc.
6.1.10.1. Company Overview
6.1.10.2. Financial Performance
6.1.10.3. Product Benchmarking
6.1.10.4. Strategic Initiatives
6.1.11. Nelson Labs
6.1.11.1. Company Overview
6.1.11.2. Financial Performance
6.1.11.3. Product Benchmarking
6.1.11.4. Strategic Initiatives



List of Figures

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market formulation & validation
Fig. 7 North America & Europe preclinical medical device testing services: Market snapshot
Fig. 8 North America & Europe preclinical medical device testing services: Market segmentation
Fig. 9 North America & Europe preclinical medical device testing services market strategy framework
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 North America & Europe preclinical medical device testing services market driver impact
Fig. 13 North America & Europe preclinical medical device testing services restraint impact
Fig. 14 North America & Europe preclinical medical device testing services market porter’s five forces analysis
Fig. 15 North America & Europe preclinical medical device testing services market PESTEL analysis
Fig. 16 North America & Europe preclinical medical device testing services market: services segment dashboard
Fig. 17 North America & Europe preclinical medical device testing services market: service movement analysis
Fig. 18 Biocompatibility tests market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 19 Chemistry test market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 20 Microbiology & sterility testing market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 21 Package Validation market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 22 North America & Europe preclinical medical device testing services market: Segment dashboard
Fig. 23 North America & Europe preclinical medical device testing services market: test type movement analysis
Fig. 24 North America & Europe preclinical medical device testing services market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 25 Global North America & Europe preclinical medical device testing services market: Regional movement analysis
Fig. 26 Global North America & Europe preclinical medical device testing services market: Regional outlook and key takeaways
Fig. 27 North America market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 28 U.S. market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 29 Canada market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 30 Europe market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 31 U.K. market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 32 Germany market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 33 France market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 34 Italy market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 35 Spain market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 36 Netherlands market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 37 Belgium market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 38 Switzerland market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 39 Russia market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 40 Sweden market estimates and forecast, 2016 - 2028 (USD Million)

List of Tables

List of Tables

Table 1 North America & Europe Preclinical Medical Device Testing Services Market, by Region, 2016 - 2028 (USD Million)
Table 2 North America & Europe Preclinical Medical Device Testing Services Market, by Service, 2016 - 2028 (USD Million)
Table 3 North America & Europe Microbiology & Sterility Testing Market, by Test Type, 2016 - 2028 (USD Million)
Table 4 North America Preclinical Medical Device Testing Services Market, by Region, 2016 - 2028 (USD Million)
Table 5 North America Preclinical Medical Device Testing Services Market, by Service, 2016 - 2028 (USD Million)
Table 6 North America Microbiology & Sterility Testing Market, by Test Type, 2016 - 2028 (USD Million)
Table 7 U.S. Preclinical Medical Device Testing Services Market, by Service, 2016 - 2028 (USD Million)
Table 8 U.S. Microbiology & Sterility Testing Market, by Test Type, 2016 - 2028 (USD Million)
Table 9 Canada Preclinical Medical Device Testing Services Market, by Service, 2016 - 2028 (USD Million)
Table 10 Canada Microbiology & Sterility Testing Market, by Test Type, 2016 - 2028 (USD Million)
Table 11 Europe Preclinical Medical Device Testing Services Market, by Region, 2016 - 2028 (USD Million)
Table 12 Europe Preclinical Medical Device Testing Services Market, by Service, 2016 - 2028 (USD Million)
Table 13 Europe Microbiology & Sterility Testing Market, by Test Type, 2016 - 2028 (USD Million)
Table 14 U.K. Preclinical Medical Device Testing Services Market, by Service, 2016 - 2028 (USD Million)
Table 15 U.K. Microbiology & Sterility Testing Market, by Test Type, 2016 - 2028 (USD Million)
Table 16 Germany Preclinical Medical Device Testing Services Market, by Service, 2016 - 2028 (USD Million)
Table 17 Germany Microbiology & Sterility Testing Market, by Test Type, 2016 - 2028 (USD Million)
Table 18 France Preclinical Medical Device Testing Services Market, by Service, 2016 - 2028 (USD Million)
Table 19 France Microbiology & Sterility Testing Market, by Test Type, 2016 - 2028 (USD Million)
Table 20 Italy Preclinical Medical Device Testing Services Market, by Service, 2016 - 2028 (USD Million)
Table 21 Italy Microbiology & Sterility Testing Market, by Test Type, 2016 - 2028 (USD Million)
Table 22 Spain Preclinical Medical Device Testing Services Market, by Service, 2016 - 2028 (USD Million)
Table 23 Spain Microbiology & Sterility Testing Market, by Test Type, 2016 - 2028 (USD Million)
Table 24 Netherlands Preclinical Medical Device Testing Services Market, by Service, 2016 - 2028 (USD Million)
Table 25 Netherlands Microbiology & Sterility Testing Market, by Test Type, 2016 - 2028 (USD Million)
Table 26 Belgium Preclinical Medical Device Testing Services Market, by Service, 2016 - 2028 (USD Million)
Table 27 Belgium Microbiology & Sterility Testing Market, by Test Type, 2016 - 2028 (USD Million)
Table 28 Switzerland Preclinical Medical Device Testing Services Market, by Service, 2016 - 2028 (USD Million)
Table 29 Switzerland Microbiology & Sterility Testing Market, by Test Type, 2016 - 2028 (USD Million)
Table 30 Russia Preclinical Medical Device Testing Services Market, by Service, 2016 - 2028 (USD Million)
Table 31 Russia Microbiology & Sterility Testing Market, by Test Type, 2016 - 2028 (USD Million)
Table 32 Sweden Preclinical Medical Device Testing Services Market, by Service, 2016 - 2028 (USD Million)
Table 33 Sweden Microbiology & Sterility Testing Market, by Test Type, 2016 - 2028 (USD Million)